General - Press Releases

Date	Title	Company
13-Jan-2021	Global Pegfilgrastim Biosimilars Market Opportunities and Strategies to 2030 - ResearchAndMarkets.com	Businesswire
13-Jan-2021	Global Language Services Market Insights & Forecast Report 2020-2024: Focus on Translation, Interpretation & Speech Recognition - ResearchAndMarkets.com	Businesswire
13-Jan-2021	Jasper Therapeutics and Graphite Bio Announce Collaboration to Evaluate JSP191 as Conditioning Regimen for Novel Gene Replacement Therapy in Patients with XSCID	Businesswire
13-Jan-2021	Ligand Receives Milestone Payment from Merck	Businesswire
13-Jan-2021	Philogen Announces the Completion of a Second Interim Analysis of Its Phase III Clinical Program With Nidlegy for the Treatment of Melanoma	Newswire
13-Jan-2021	Wipro Limited Announces Results for the Quarter ended December 31, 2020 under IFRS	Businesswire
13-Jan-2021	SCHOTT’s Lebanon, Pa. Facility Reaches New Record in Glass Vial Production for COVID-19 Vaccine	Businesswire
13-Jan-2021	Sesen Bio and Qilu Pharmaceutical Announce IND Application for Vicineum™ Accepted for Review by the National Medical Products Administration in China	Businesswire
13-Jan-2021	New Research Data Across DXd ADC Portfolio at WCLC Showcases Daiichi Sankyo’s Continued Commitment in Lung Cancer	Businesswire
13-Jan-2021	Massive Bio Launches Industry’s First NASA-Style, Oncology Clinical Trial Command Center to Disrupt and Accelerate Trial Enrollment, Featuring 72-Hour Instant Enrollment from Time of Patient Identification	Businesswire
13-Jan-2021	TruTrace Technologies Appoints Two New Members to Board of Directors	Businesswire
13-Jan-2021	North America Sterilization Equipment Market to 2028 - Featuring 3M, Cantel Medical and Cardinal Health Among Others - ResearchAndMarkets.com	Businesswire
13-Jan-2021	Drug Development in Rare Diseases, 2021 Report: Focus on Clinical Trials and the Regulatory Landscape - ResearchAndMarkets.com	Businesswire
13-Jan-2021	Raiven Capital Announces $25M First Close Amid Global Pandemic	Businesswire
13-Jan-2021	Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for Filing of New Drug Application (NDA) for the Use of Ganaxolone in CDKL5 Deficiency Disorder (CDD)	Businesswire
13-Jan-2021	Vaxxinity to Present at the 39th Annual J.P. Morgan Healthcare Conference	Businesswire
13-Jan-2021	HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization	Businesswire
13-Jan-2021	KSQ Therapeutics and Takeda Enter Broad Strategic Collaboration to Research, Develop and Commercialize Novel Immuno-Oncology Therapies	Businesswire
13-Jan-2021	Glaukos’ iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 24 Months in Phase 2b Study	Businesswire
13-Jan-2021	Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2020 Net Sales	Businesswire